Home
Ikarian Capital reported a 11.4% stake in Spruce Biosciences SPRB · 121,356 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 11.4%
- Last report
- 21.6% · filed 25/10/08
- Shares held
- 121,356 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- Ikarian Capital
- Event date
- 25/10/31
- Filed
- 25/11/07
11.4% stake · −10.2pp from the last report
- Stake
- 11.4%
- Last report
- 21.6%
- Since last report
- −10.2pp
Spruce Biosciences trades, last 26 weeks
What else happened in Spruce Biosciences around then
Filed or reported within 30 days of the trade day · 25/10/01~25/11/30Ikarian Capital's other 5% stake reports
- Ikarian Capital
5% stakeCNS Pharmaceuticals
5% stakeCNS Pharmaceuticals
CNSP
9.9% stake
147,290 sh
9.9% stake
Filed 08/14
- Ikarian Capital
5% stakeConnect Biopharma Holdings
5% stakeConnect Biopharma Holdings
CNTB
6.9% stake
4,338,534 sh
6.9% stake
Filed 08/14
- Ikarian Capital
5% stakeQuince Therapeutics
5% stakeQuince Therapeutics
QNCX
9% stake
91,789 sh
9% stake
Filed 08/14
- Ikarian Capital
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
2.9% stake
1,080,700 sh
2.9% stake
Filed 08/14
- Ikarian Capital
5% stakeInMed Pharmaceuticals
5% stakeInMed Pharmaceuticals
INM
4.2% stake
137,634 sh
4.2% stake
Filed 08/14
